Nunzia Pharmaceutical Company
OTC: NUNZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Sara Gonzales
- Employees
- 4
- Headquarters
- Long Beach, United States
- IPO year
- 2009
- Market cap
- $43.5K
- Website
- https://www.nunziapharma.com
Loading NUNZ…
Loading profile data…Frequently asked questions about NUNZ
What does Nunzia Pharmaceutical Company (NUNZ) do?
Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company wa...
Where does NUNZ trade?
Nunzia Pharmaceutical Company (NUNZ) trades on the Other OTC.
What sector is NUNZ in?
Nunzia Pharmaceutical Company (NUNZ) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Nunzia Pharmaceutical Company?
Sara Gonzales is the chief executive officer of Nunzia Pharmaceutical Company (NUNZ).
Where is Nunzia Pharmaceutical Company headquartered?
Nunzia Pharmaceutical Company is headquartered in United States.
Does NUNZ pay a dividend?
Nunzia Pharmaceutical Company (NUNZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NUNZ go public?
Nunzia Pharmaceutical Company (NUNZ) completed its initial public offering in 2009.